disease management

current treatments

There is trend towards convergence in gold standard treatments and investigations throughout the developed world, but country and regional patterns remain. The treatment of choice in one country may not be well accepted in another, driven by factors such as key opinion leader influence, medical school training, historical patterns of service provision, culture, and reimbursement codes. In developing clinical and cost effectiveness dossiers it is important to select the most relevant comparator(s) for each target market. Translucency advises on current treatments in different countries so that appropriate comparator(s) can be selected.